4. Application

The Sanakin-Technology is an innovative development in which a completely autologous cytokine-rich serum (ACRS) is obtained from the patient’s own blood to ensure the effectiveness and success of the treatment.

This serum contains high concentration of cytokines – signaling proteins that control inflammation and tissue regeneration processes. When multiplied, these body’s own messenger substances can act exactly where they are needed.

Regulating inflammation and accelerated tissue regeneration is an important topic for physicians in many specialties. This is where Sanakin makes
a decisive contribution and enables new impulses for personalized therapies.

Our goal is to continuously advance our technology for creating an autologous serum. In order to achieve this, we are looking for doctors who
specialize in regenerative medicine and who are eager to use personalized therapies for their patients.

In 2010 the first company was established to start working with the body’s own immune proteins in orthopedics – the beginning of the Sanakin Technology.
The results were so encouraging that we expanded our technology to other specialties and countries.

At the same time, we also transferred this approach to veterinary medicine: with Ferakin we have created a way to treat any type of inflammation in pets and
livestock 100% autologously.

In the following years we will expand our business globally and have already established several local subsidiaries and successful global partnerships.